Cargando…
Considerations for Selecting Cognitive Endpoints and Psychological Patient-Reported Outcomes for Clinical Trials in Pediatric Patients With Sickle Cell Disease
Pediatric patients with sickle cell disease (SCD) experience a range of medical complications that result in significant morbidity and mortality. Recent advances in prophylactic and curative treatment approaches have highlighted the need for sensitive and clinically-meaningful trial endpoints. The d...
Autores principales: | Hood, Anna M., Crosby, Lori E., Stotesbury, Hanne, Kölbel, Melanie, Kirkham, Fenella J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253275/ https://www.ncbi.nlm.nih.gov/pubmed/35800079 http://dx.doi.org/10.3389/fneur.2022.835823 |
Ejemplares similares
-
Effects of regional brain volumes on cognition in sickle cell anemia: A developmental perspective
por: Hamdule, Shifa, et al.
Publicado: (2023) -
Mind the gap: trajectory of cognitive development in young individuals with sickle cell disease: a cross-sectional study
por: Koelbel, Melanie, et al.
Publicado: (2023) -
Exploring the relationship of sleep, cognition, and cortisol in sickle cell disease
por: Kölbel, Melanie, et al.
Publicado: (2022) -
Quantitative susceptibility mapping (QSM) and R2(*) of silent cerebral infarcts in sickle cell anemia
por: Murdoch, Russell, et al.
Publicado: (2022) -
Vascular Instability and Neurological Morbidity in Sickle Cell Disease: An Integrative Framework
por: Stotesbury, Hanne, et al.
Publicado: (2019)